Neuroprotective effects of Erigeron Breviscapus (vant) Hand-Mazz on NMDA-induced retinal neuron injury in the rats

International Journal of Ophthalmology

Volumn 5, Issue 5, 2005, Pages 859-863

  Shi, Jing Ming ^a   Jiang, You Qin ^a   Liu, Xu Yang ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Erigeron breviscapus(vant) hand mazz (EBHM); Excitatory amino acids; Glaucoma; N methyl D aspartate; Neuroprotection

Indexed keywords

CHINESE DRUG; ERIGERON BREVISCAPUS EXTRACT; EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LOSS; CHINESE HERB; CONTROLLED STUDY; ERIGERON BREVISCAPUS; GLAUCOMA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; RETINA GANGLION CELL; RETINA INJURY; RETINA NERVE CELL; STATISTICAL SIGNIFICANCE;

EID: 28644444399     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jiang Y, Liu X. Neuroprotection- New concept in glaucoma therapy. In: Yuan J eds. The Frontier of Ophthalmology in the 21st Century. Tianjin: Tianjin Science and Technology Press,2001:541-554
2. Weinreb RN, Levin LA. Is neuroprotection a viable therapy for glaucoma? Arch Ophthalmol,1999;117:1540-1544
3. Gross RL. Clinical glaucoma management. Philadelphia, W.B Saunders Company,2001:45-47
4. Yoles E, Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol,1998;42:367-372
5. Jiang Y, Wu Z, Mo X. An approach to treat the late stage glaucoma with intraocular pressure controlled after trabeculectomy. Chin Ophthalmic Res, 1991;9:229-232
6. Jia L, Jiang Y, Wu Z. The clinical effect of Qing Guang Kang on glaucomatous patients whose IOP were controlled. Chin J Pract Ophthalmol,1994; 12:269-273
7. Ye C, Jiang Y. A clinical study of the neuroprotection effect of Erigeron Breviscapus (vant) Hand-Mazz on glaucomatous patient eyes. Chin Ophthal Res,2003;21:307-311
8. Jia L, Liu Z, Luo X, Jiang Y, Luo X, Liu D. The effect of Qing Guang Kang on the metabolism of retinal ganglionic cells of rats after artificial acute high intraocular pressure. Chin J Ophthalmol,1995;31:129-131
9. Wang NL, Sun XH, Li JZ, Wang JH, Chen XM, Lin D, Lü JH, Zhong YS, Zhang C, Guo WY. Neuroprotective effects of erigeron breviscapus (vant) hand-mass on glaucoma- A mulli-Center clinical trial. Int J Ophthalmol (Guoji Yanke Zazhi),2004;4(4):587-592
10. Zhu Y, Jiang Y, Liu Z, Luo X, Wu Z. The affect of Erigeron Breviscapus (vant) Hand-Mazz on axoplasmic transport of optic nerve in rats with experimentally elevated intraocular pressure. Chin J Ophthalmol,2000;36: 289-291
11. Jiang BQ, Jiang Y. The neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury. Chin J Ophthalmol,2003;39:481-484
12. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron,1995; 15:961-973
13. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med,1994;330:613-622